Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 2
1984 2
1986 1
1988 1
1989 1
1990 3
1991 1
1992 1
1993 2
1994 1
1997 2
2000 1
2002 1
2003 1
2004 2
2005 5
2006 1
2007 5
2008 4
2009 13
2010 14
2011 31
2012 33
2013 29
2014 33
2015 35
2016 45
2017 47
2018 55
2019 51
2020 39
2021 45
2022 36
2023 39
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

567 results

Results by year

Filters applied: . Clear all
Page 1
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation.
Gulla A, Morelli E, Samur MK, Botta C, Hideshima T, Bianchi G, Fulciniti M, Malvestiti S, Prabhala RH, Talluri S, Wen K, Tai YT, Richardson PG, Chauhan D, Sewastianik T, Carrasco RD, Munshi NC, Anderson KC. Gulla A, et al. Among authors: botta c. Blood Cancer Discov. 2021 Sep;2(5):468-483. doi: 10.1158/2643-3230.BCD-21-0047. Epub 2021 Apr 23. Blood Cancer Discov. 2021. PMID: 34568832 Free PMC article.
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Larrayoz M, Garcia-Barchino MJ, Celay J, Etxebeste A, Jimenez M, Perez C, Ordoñez R, Cobaleda C, Botta C, Fresquet V, Roa S, Goicoechea I, Maia C, Lasaga M, Chesi M, Bergsagel PL, Larrayoz MJ, Calasanz MJ, Campos-Sanchez E, Martinez-Cano J, Panizo C, Rodriguez-Otero P, Vicent S, Roncador G, Gonzalez P, Takahashi S, Katz SG, Walensky LD, Ruppert SM, Lasater EA, Amann M, Lozano T, Llopiz D, Sarobe P, Lasarte JJ, Planell N, Gomez-Cabrero D, Kudryashova O, Kurilovich A, Revuelta MV, Cerchietti L, Agirre X, San Miguel J, Paiva B, Prosper F, Martinez-Climent JA. Larrayoz M, et al. Among authors: botta c. Nat Med. 2023 Mar;29(3):632-645. doi: 10.1038/s41591-022-02178-3. Epub 2023 Mar 16. Nat Med. 2023. PMID: 36928817 Free PMC article.
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Fazio M, Del Fabro V, Parrinello NL, Allegra A, Markovic U, Botta C, Accardi F, Vincelli ID, Leotta S, Elia F, Esposito B, Garibaldi B, Sapuppo G, Orofino A, Romano A, Palumbo GA, Di Raimondo F, Conticello C. Fazio M, et al. Among authors: botta c. Curr Oncol. 2023 Nov 3;30(11):9710-9733. doi: 10.3390/curroncol30110705. Curr Oncol. 2023. PMID: 37999125 Free PMC article. Review.
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma.
Battaglia AM, Sacco A, Aversa I, Santamaria G, Palmieri C, Botta C, De Stefano R, Bitetto M, Petriaggi L, Giorgio E, Faniello CM, Costanzo F, Biamonte F. Battaglia AM, et al. Among authors: botta c. Front Cell Dev Biol. 2023 Jun 12;11:1208485. doi: 10.3389/fcell.2023.1208485. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37377735 Free PMC article.
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
Botta C, Perez C, Larrayoz M, Puig N, Cedena MT, Termini R, Goicoechea I, Rodriguez S, Zabaleta A, Lopez A, Sarvide S, Blanco L, Papetti DM, Nobile MS, Besozzi D, Gentile M, Correale P, Siragusa S, Oriol A, González-Garcia ME, Sureda A, de Arriba F, Rios Tamayo R, Moraleda JM, Gironella M, Hernandez MT, Bargay J, Palomera L, Pérez-Montaña A, Goldschmidt H, Avet-Loiseau H, Roccaro A, Orfao A, Martinez-Lopez J, Rosiñol L, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Martinez Climent JA, Paiva B; Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) cooperative group; iMMunocell study group. Botta C, et al. Nat Commun. 2023 Sep 20;14(1):5825. doi: 10.1038/s41467-023-41562-6. Nat Commun. 2023. PMID: 37730678 Free PMC article.
Observation of the B_{c}^{+} Meson in Pb-Pb and pp Collisions at sqrt[s_{NN}]=5.02  TeV and Measurement of its Nuclear Modification Factor.
Tumasyan A, Adam W, Andrejkovic JW, Bergauer T, Chatterjee S, Dragicevic M, Del Valle AE, Frühwirth R, Jeitler M, Krammer N, Lechner L, Liko D, Mikulec I, Paulitsch P, Pitters FM, Schieck J, Schöfbeck R, Schwarz D, Templ S, Waltenberger W, Wulz CE, Chekhovsky V, Litomin A, Makarenko V, Darwish MR, De Wolf EA, Janssen T, Kello T, Lelek A, Sfar HR, Van Mechelen P, Van Putte S, Van Remortel N, Blekman F, Bols ES, D'Hondt J, Delcourt M, Faham HE, Lowette S, Moortgat S, Morton A, Müller D, Sahasransu AR, Tavernier S, Van Doninck W, Van Mulders P, Beghin D, Bilin B, Clerbaux B, De Lentdecker G, Favart L, Grebenyuk A, Kalsi AK, Lee K, Mahdavikhorrami M, Makarenko I, Moureaux L, Pétré L, Popov A, Postiau N, Starling E, Thomas L, Vanden Bemden M, Vander Velde C, Vanlaer P, Wezenbeek L, Cornelis T, Dobur D, Knolle J, Lambrecht L, Mestdach G, Niedziela M, Roskas C, Samalan A, Skovpen K, Tytgat M, Vermassen B, Vit M, Benecke A, Bethani A, Bruno G, Bury F, Caputo C, David P, Delaere C, Donertas IS, Giammanco A, Jaffel K, Jain S, Lemaitre V, Mondal K, Prisciandaro J, Taliercio A, Teklishyn M, Tran TT, Vischia P, Wertz S, Alves GA, Hensel C, Moraes A, Júnior WLA, Pereira MAG, Filho MBF, Malbouis… See abstract for full author list ➔ Tumasyan A, et al. Among authors: botta c. Phys Rev Lett. 2022 Jun 24;128(25):252301. doi: 10.1103/PhysRevLett.128.252301. Phys Rev Lett. 2022. PMID: 35802434 Free article.
Could PD-1/PDL1 immune checkpoints be linked to HLA signature?
Correale P, Saladino RE, Nardone V, Giannicola R, Agostino R, Pirtoli L, Caraglia M, Botta C, Tagliaferri P. Correale P, et al. Among authors: botta c. Immunotherapy. 2019 Dec;11(18):1523-1526. doi: 10.2217/imt-2019-0160. Epub 2019 Dec 9. Immunotherapy. 2019. PMID: 31865873 Free article. No abstract available.
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.
Termini R, Žihala D, Terpos E, Perez-Montaña A, Jelínek T, Raab M, Weinhold N, Mai EK, Grab AL, Corre J, Vergez F, Sacco A, Chiarini M, Giustini V, Tucci A, Rodriguez S, Moreno C, Perez C, Maia C, Martín-Sánchez E, Guerrero C, Botta C, Garces JJ, Lopez A, Tamariz-Amador LE, Prosper F, Bargay J, Cabezudo ME, Ocio EM, Hájek R, Martinez-Lopez J, Solano F, Iglesias R, Paiva A, Geraldes C, Vitoria H, Gomez C, De Arriba F, Ludwig H, Garcia-Guiñon A, Casanova M, Alegre A, Cabañas V, Sirvent M, Oriol A, de la Rubia J, Hernández-Rivas JÁ, Palomera L, Sarasa M, Rios P, Puig N, Mateos MV, Flores-Montero J, Orfao A, Goldschmidt H, Avet-Loiseau H, Roccaro AM, San-Miguel JF, Paiva B; PETHEMA/GEM and iMMunocell Cooperative Groups. Termini R, et al. Among authors: botta c. Clin Cancer Res. 2022 Nov 1;28(21):4771-4781. doi: 10.1158/1078-0432.CCR-22-1594. Clin Cancer Res. 2022. PMID: 36074126
Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome.
Plano F, Gigliotta E, Corsale AM, Azgomi MS, Santonocito C, Ingrascì M, Di Carlo L, Augello AE, Speciale M, Vullo C, Rotolo C, Camarda GM, Caccamo N, Meraviglia S, Dieli F, Siragusa S, Botta C. Plano F, et al. Among authors: botta c. Int J Mol Sci. 2023 May 16;24(10):8852. doi: 10.3390/ijms24108852. Int J Mol Sci. 2023. PMID: 37240197 Free PMC article.
Mouse models of multiple myeloma: technologic platforms and perspectives.
Rossi M, Botta C, Arbitrio M, Grembiale RD, Tagliaferri P, Tassone P. Rossi M, et al. Among authors: botta c. Oncotarget. 2018 Apr 13;9(28):20119-20133. doi: 10.18632/oncotarget.24614. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29732008 Free PMC article. Review.
567 results